12.07.2015 Views

nhs forth valley formulary 11 - Community Pharmacy

nhs forth valley formulary 11 - Community Pharmacy

nhs forth valley formulary 11 - Community Pharmacy

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Forth Valley Formulary Eleventh Edition 2012/13Chapter/Section/Drug Primary Care AcuteCHPsMentalHealthSpecialtiesServices6.6.2 BisphosphonatesComment Please refer to Hypercalcaemia of Malignancy Treatment Guideline (Appendix 19) & SuspectedHypercalcaemia of Malignancy Guideline for Primary Care (Appendix 20)Alendronic Acid (1 st Line) (prophylaxis and treatment in men and women)Risedronate Sodium (prophylaxis and treatment in women only) (2 nd Line inpatients with G.I. problems)Comment Risedronate 2 nd Line if GI intolerance of alendronic acid. Recommended in G.I problems. Caution ensurecorrect strength is prescribed for indication.Disodium Pamidronate(I.V.)- (1 st Line for hypercalcaemia)Zoledronic Acid Sol’n (2 nd line)Ibandronic Acid-(3 rd Line) Denosumab (Restricted to specialist recommendation in secondary care in women only)Strontium ranelate (Protelos®) Comment Strontium ranelate 2 nd Line to bisphosphonates for patients who cannot tolerate bisphosphonatesRaloxifene Comment Rafoxifene may be used for patients where bisphosphonates and Stontium are contra indicated or nottolerated6.7 Other endocrine drugs6.7.1 Bromocriptine and other dopamine-receptor stimulantsBromocriptine Cabergoline Quinagolide 6.7.2 Drugs affecting gonadotrophinsDanazol Naferelin Page 29

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!